Jefferson Capital buys and services portfolios of charged-off and insolvency-related consumer receivables from banks, fintechs, auto lenders, telecoms, utilities, and other credit originators. Using data-driven pricing and collections operations across the U.S., Canada, the U.K., and Latin America, it monetizes nonperforming accounts while originators free capital and focus on active customers. Its multi-asset-class approach—including auto, cards, installment loans, and other consumer debts—distinguishes it among specialty debt purchasers.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 154.9 | — | 64.2 | — |
| Q2 2025 | 152.7 | — | 47.6 | — |
| Q3 2025 | 150.8 | — | 34.6 | — |
| Q4 2025 | 154.8 | — | 52.6 | — |
| Q1 2026 | 176.4 | 13.9% | 33.8 | -47.4% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: GoodRx Holdings, Inc. (GDRX), Monte Rosa Therapeutics, Inc. (GLUE), Grocery Outlet Holding Corp. (GO), Corvus Pharmaceuticals, Inc. (CRVS), Odyssey Therapeutics, Inc. (ODTX), Marten Transport, Ltd. (MRTN)